Hagerman, Randi J.
University of California Davis Medical Center · University of California, Davis
56 papers on CoChatORCID 0000-0001-5029-8448
Most cited papers
- Verified
Psychiatric Phenotype of the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in Males: Newly Described Fronto-Subcortical Dementia
Bacalman, S., Farzin, F., Bourgeois, J. A., Cogswell, J., Goodlin-Jones, B. L., Gane, L. W., Grigsby, J., Leehey, M. A., Tassone, F., & Hagerman, R. J. (2006) · The Journal of Clinical Psychiatry
Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases
Cited by 175
- Verified
The Prader-Willi phenotype of fragile X syndrome
Nowicki, S. T., Tassone, F., Ono, M. Y., Ferranti, J., Croquette, M. F., Goodlin-Jones, B., & Hagerman, R. J. (2007) · Journal of Developmental & Behavioral Pediatrics
Genetics and Neurodevelopmental DisordersGenetic Syndromes and Imprinting
Cited by 174
- Verified
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
Dziembowska, M., Pretto, D. I., Janusz, A., Kaczmarek, L., Leigh, M. J., Gabriel, N., Durbin‐Johnson, B., Hagerman, R. J., & Tassone, F. (2013) · American Journal of Medical Genetics Part A
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 161
- Verified
Fragile X syndrome
McLennan, Y., Polussa, J., Tassone, F., & Hagerman, R. (2011) · Current Genomics
Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases
Cited by 160
- Verified
A controlled trial of stimulant medication in children with the fragile X syndrome
Hagerman, R. J., Murphy, M. A., & Wittenberger, M. D. (1988) · American Journal of Medical Genetics
Genetics and Neurodevelopmental DisordersAttention Deficit Hyperactivity Disorder
Cited by 158
- Verified
Effect of CX516, an AMPA-Modulating Compound, on Cognition and Behavior in Fragile X Syndrome: AControlled Trial
Berry-Kravis, E., Krause, S. E., Block, S. S., Guter, S., Wuu, J., Leurgans, S., Decle, P., Potanos, K., Cook, E., Salt, J., et al. (2006) · Journal of Child and Adolescent Psychopharmacology
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 155
- Verified
Profile of cognitive functioning in women with the fragile X mutation.
Bennetto, L., Taylor, A. K., Pennington, B. F., Porter, D., & Hagerman, R. J. (2001) · Neuropsychology
Genetics and Neurodevelopmental DisordersWilliams Syndrome Research
Cited by 135
- Verified
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results
FragXis Study Group, Youssef, E. A., Berry-Kravis, E., Czech, C., Hagerman, R. J., Hessl, D., Wong, C. Y., Rabbia, M., Deptula, D., John, A., et al. (2018) · Neuropsychopharmacology
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 133
- Verified
Metformin as targeted treatment in fragile X syndrome
Dy, A. B. C., Tassone, F., Eldeeb, M., Salcedo‐Arellano, M. J., Tartaglia, N., & Hagerman, R. (2018) · Clinical Genetics
Genetics and Neurodevelopmental DisordersGenetic Syndromes and Imprinting
Cited by 124
- Verified
A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome
Greiss Hess, L., Fitzpatrick, S. E., Nguyen, D. V., Chen, Y., Gaul, K. N., Schneider, A., Lemons Chitwood, K., Eldeeb, M. A. A. A., Polussa, J., Hessl, D., et al. (2016) · Journal of Developmental & Behavioral Pediatrics
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 122
- Verified
Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder
Chonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M., Mu, Y., Tassone, F., Nguyen, D. V., & Hagerman, R. J. (2012) · Human Genetics
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 109
- Verified
Tremor and ataxia in fragile X premutation carriers: Blinded videotape study
Berry‐Kravis, E., Lewin, F., Wuu, J., Leehey, M., Hagerman, R., Hagerman, P., & Goetz, C. G. (2003) · Annals of Neurology
Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases
Cited by 109
- Verified
Electrocortical changes associated with minocycline treatment in fragile X syndrome
Schneider, A., Leigh, M. J., Adams, P., Nanakul, R., Chechi, T., Olichney, J., Hagerman, R., & Hessl, D. (2013) · Journal of Psychopharmacology
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 108
- Verified
Side Effects of Minocycline Treatment in Patients With Fragile X Syndrome and Exploration of Outcome Measures
Utari, A., Chonchaiya, W., Rivera, S. M., Schneider, A., Hagerman, R. J., Faradz, S. M. H., Ethell, I. M., & Nguyen, D. V. (2010) · American Journal on Intellectual and Developmental Disabilities
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 105
- Verified
A double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of fragile X syndrome
Berry-Kravis, E., Horrigan, J. P., Tartaglia, N., Hagerman, R., Kolevzon, A., Erickson, C. A., Hatti, S., Snape, M., Yaroshinsky, A., Stoms, G., et al. (2020) · Pediatric Neurology
Genetics and Neurodevelopmental DisordersAlzheimer's disease research and treatments
Cited by 102
- Verified
Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome
Greco, C. M., Navarro, C. S., Hunsaker, M. R., Maezawa, I., Shuler, J. F., Tassone, F., Delany, M., Au, J. W., Berman, R. F., Jin, L.-W., et al. (2011) · Molecular Autism
Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases
Cited by 90
- Verified
FMR1 premutation and full mutation molecular mechanisms related to autism
Hagerman, R., Au, J., & Hagerman, P. (2011) · Journal of Neurodevelopmental Disorders
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 85
- Verified
Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism
Schapiro, M. B., Murphy, D. G. M., Hagerman, R. J., Azari, N. P., Alexander, G. E., Miezejeski, C. M., Hinton, V. J., Horwitz, B., Haxby, J. V., Kumar, A., et al. (1995) · American Journal of Medical Genetics
Genetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research
Cited by 85
- Verified
Plasma cytokine profiles in Fragile X subjects: Is there a role for cytokines in the pathogenesis?
Ashwood, P., Nguyen, D. V., Hessl, D., Hagerman, R. J., & Tassone, F. (2010) · Brain, Behavior, and Immunity
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 80
- Verified
Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder
García‐Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., Marvin, E., Tassone, F., & Hagerman, R. J. (2008) · American Journal of Medical Genetics Part A
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 76
- Verified
Auditory evoked magnetic fields in adults with fragile X syndrome.
Rojas, D. C., Benkers, T. L., Rogers, S. J., Teale, P. D., Reite, M. L., & Hagerman, R. J. (2001) · Neuroreport
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 73
- Verified
Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder
Thurman, A. J., McDuffie, A., Hagerman, R., & Abbeduto, L. (2014) · Research in Developmental Disabilities
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 70
- Verified
Metformin treatment in young children with fragile X syndrome
Biag, H. M. B., Potter, L. A., Wilkins, V., Afzal, S., Rosvall, A., Salcedo‐Arellano, M. J., Rajaratnam, A., Manzano‐Nunez, R., Schneider, A., Tassone, F., et al. (2019) · Molecular Genetics & Genomic Medicine
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 68
- Verified
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
Thurman, A. J., Potter, L. A., Kim, K., Tassone, F., Banasik, A., Potter, S. N., Bullard, L., Nguyen, V., McDuffie, A., Hagerman, R., et al. (2020) · Journal of Neurodevelopmental Disorders
Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research
Cited by 58
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free